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Background: Newer generation drug-eluting stents (DES) have applied better polymers including biodegradable one, however the long-term safety 
is still unclear. The aim of this study was to evaluate the long-term safety following sirolimus eluting (SES), everolimus eluting (EES), and biolimus 
eluting stent (BES) in porcine coronary artery model.
Methods: SES, EES, and BES were implanted in each coronary artery of 12 mini-swine. Animals were sacrificed at 3 and 6 months (n=6 each). 
Six animals for 6-months period received acetylcholine challenge tests and optical coherence tomography (OCT) examination at 1 month. After the 
euthanasia, stents were histologically analyzed in order to investigate the inflammatory reaction.
Results: At 1 month, acetylcholine challenge tests revealed the greatest vaso-constriction in SES compared with EES and BES in both proximal 
and distal segments, while in the proximal segment, BES showed slightly greater vaso-constriction compared with EES. OCT analysis demonstrated 
the greatest incidence of uncovered struts in SES (41.7±27.0%) followed by BES (24.5±23.8%), while EES showed almost complete stent coverage 
(0.4±0.8%, p=0.004). In histologic analysis at 3 months, SES showed significantly greater inflammatory score (2.9±1.4, p=0.001) with higher 
incidence of struts with granulomatous reaction (45.5±34.1%, p=0.003) compared with BES (inflammatory reaction 0.8±0.9, granuloma 5.1±7.3%) 
and EES (inflammatory reaction 0.5±0.4, granuloma 2.3±3.5%). SES continued to show severe inflammation (inflammatory score 1.7±0.7, p=0.05) 
at 6 months, while BES (1.0±0.3) and EES (0.9±0.7) sustained minimal inflammatory reaction.
Conclusions: While SES consistently showed a progressive increase in inflammatory reaction, EES and BES showed minimal inflammation even 
after the long-term follow-up. In addition, the coverage of stent struts was more rapidly completed in EES as compare to BES and SES, which was 
confirmed by OCT analysis at 1 month. Late inflammatory reaction does not necessarily depend on degradability of the polymer if the materials are 
sufficiently biocompatible.
